Ongoing CE Activities

Proceedings from the 15th Annual Winter Lung Cancer Conference

Adding Local Tx Boosts Survival in Advanced NSCLC

Advanced Non-Small Cell Lung Ccancer Patient Management Simulator

An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease

ASTRO Issues New Guidelines on Stereotactic Radiation in Early NSCLC

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Lung Cancer

Biomarker Analysis and the Implications for the Treatment of Non-Small Cell Lung Cancer

Case Studies in ALK-Translocated Advanced NSCLC: From Diagnosis to Treatment

Checkpoint Inhibitors in First-Line Advanced NSCLC: What Should You Know?

Clinical Challenges and Best Practices in Managing ALK-Positive NSCLC

Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer

Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial

NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non–Small Cell Lung Cancer

EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine

Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer Management

Immune Checkpoint Inhibitors in Lung Cancer: No Longer the Road Less Traveled?

The Evolving Landscape of Immunotherapy and Targeted Therapy for Non–Small Cell Lung Cancer

Immunotherapy in Advanced NSCLC: Will Combination Therapies Become Standard?

Improving Outcomes for Patients With Non–Small Cell Lung Cancer

Integrating Targeted Strategies in NSCLC

Integration of Immunotherapies Into the Treatment of Patients With Non–Small Cell Lung Cancer

JADPRO Regional Lectures: Immunotherapy: Case Studies in Non-Small Cell Lung Cancer

Lung Cancer series

Lung Cancer Update, Issue 2, 2017

Management of Advanced NSCLC: Where Do Immune Checkpoint Inhibitors Fit In?:

Minimizing the Impact of imAEs and Maximizing Efficacy: Pulmonary Toxicity

NCCN Continuing Education in Lung Cancer

NCCN Launches NCCN Congress Webinar Series™: Biomarkers 101

Oncology Grand Rounds Series: Part 1 — Non-Small Cell Lung Cancer: A satellite symposium held at the 2017 ONS Annual Congress

Oncology Grand Rounds: Non-Small Cell Lung Cancer

Optimizing Outcomes in Advanced NSCLC

Outcomes in NSCLC: A Focus on Quality Improvement - Part 1

Outcomes in NSCLC: A Focus on Quality Improvement - Part 2

PD-L1 Expression Testing

Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Non-Small Cell Lung Cancer

Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy

Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events

Selecting Cancer Treatment: The Role of Tumor Molecular Profiling and Liquid Biopsy

'Smart Nose' Identifies Anti-PD-1 Response in NSCLC

Sustaining Change in Quality Improvement for NSCLC – Part 3

The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer

The Evolving Role of Biomarkers in Oncology

Time to Tailor NSCLC RT to Spare the Immune System?

Treatment of EGFR-Mutated NSCLC: Assessing Your Clinical Practice

Tumor Mutation Burden Testing

Visiting Professors: Lung Cancer Edition, Issue 1, 2019

Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers